Market Closed -
Hong Kong S.E.
04:08:28 2024-05-24 am EDT
|
5-day change
|
1st Jan Change
|
1.67
HKD
|
-6.18%
|
|
-9.73%
|
-16.08%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
13,791
|
2,426
|
2,077
|
-
|
Enterprise Value (EV)
1 |
12,743
|
2,426
|
2,077
|
2,077
|
P/E ratio
|
-3.05
x
|
-10.6
x
|
-22.1
x
|
-155
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.19
x
|
0.5
x
|
0.38
x
|
0.34
x
|
EV / Revenue
|
3.19
x
|
0.5
x
|
0.38
x
|
0.34
x
|
EV / EBITDA
|
-71.7
x
|
-17.3
x
|
45.1
x
|
14.9
x
|
EV / FCF
|
-38,099,598
x
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-
|
-
|
Price to Book
|
6.31
x
|
-
|
1.07
x
|
1.08
x
|
Nbr of stocks (in thousands)
|
1,341,473
|
1,341,473
|
1,341,473
|
-
|
Reference price
2 |
10.28
|
1.809
|
1.548
|
1.548
|
Announcement Date
|
3/28/23
|
3/28/24
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
4,329
|
4,857
|
5,429
|
6,026
|
EBITDA
1 |
-
|
-192.4
|
-140.6
|
46
|
139
|
EBIT
1 |
-
|
-327.7
|
-280.6
|
-83
|
-2
|
Operating Margin
|
-
|
-7.57%
|
-5.78%
|
-1.53%
|
-0.03%
|
Earnings before Tax (EBT)
1 |
-
|
-2,832
|
-221.2
|
-94
|
-13
|
Net income
1 |
-1,578
|
-2,833
|
-225.8
|
-92
|
-10
|
Net margin
|
-
|
-65.45%
|
-4.65%
|
-1.69%
|
-0.17%
|
EPS
2 |
-3.310
|
-3.370
|
-0.1700
|
-0.0700
|
-0.0100
|
Free Cash Flow
|
-
|
-362
|
-
|
-
|
-
|
FCF margin
|
-
|
-8.36%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/31/22
|
3/28/23
|
3/28/24
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
1,048
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-362
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-4.6%
|
-0.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-3%
|
-0.3%
|
Assets
1 |
-
|
-
|
-
|
3,067
|
3,333
|
Book Value Per Share
2 |
-
|
1.630
|
-
|
1.450
|
1.440
|
Cash Flow per Share
2 |
-
|
-
|
-
|
0.0100
|
0.0800
|
Capex
1 |
-
|
17.7
|
-
|
79
|
79
|
Capex / Sales
|
-
|
0.41%
|
-
|
1.46%
|
1.31%
|
Announcement Date
|
8/31/22
|
3/28/23
|
3/28/24
|
-
|
-
|
Last Close Price
1.548
CNY Average target price
1.366
CNY Spread / Average Target -11.76% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.08% | 287M | | -38.61% | 13.83B | | -31.33% | 10.96B | | +13.51% | 6.34B | | -8.33% | 6.08B | | -30.66% | 6.05B | | +72.00% | 5.04B | | -1.61% | 4.67B | | -4.84% | 4B | | -16.14% | 3.28B |
Other Drug Retailers
|